{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-039993","form_type":"8-K","ticker":"PRPH","cik":"0000868278","company_name":"ProPhase Labs, Inc.","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.197632+00:00","generated_at":"2026-06-08T08:17:54.575291+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"ProPhase Labs Q3 net loss $5.1M; revenue down 65% to $8.4M; plans big capacity expansion","bullets":["Q3 net loss $5.1M (-$0.30/sh) vs net income $1.0M ($0.06/sh) a year ago.","Revenue fell to $8.4M from $24.2M; gross margin dropped to 27.8% from 49.5%.","Adjusted EBITDA loss of $2.5M vs income of $6.3M in Q3 2022.","Cash & equivalents $3.3M (Dec 31, 2022: $17.4M); working capital $33.4M.","Pharmaloz capacity targets: $10M→$15M by year-end, over $75M in 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-039993","json":"https://secwatch.observer/filing/0001493152-23-039993.json","markdown":"https://secwatch.observer/filing/0001493152-23-039993.md","text":"https://secwatch.observer/filing/0001493152-23-039993.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/868278/000149315223039993/0001493152-23-039993-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/868278/000149315223039993/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T08:17:54.575291+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c99fc1b80ebd26eee5241f74e2b816d7c94eec39","claim":"ProPhase Labs, Inc. reported financial results for the three and nine months ended September 30, 2023.","evidence_excerpt":"ProPhase Labs, Inc. (the “Company”) issued a press release announcing its financial results for the third quarter ended September 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223039993/0001493152-23-039993-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three and nine months ended September 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}